Subcarinal lymph node in upper lobe non-small cell lung cancer patients: Is selective lymph node dissection valid?

Lung Cancer

Volumn 70, Issue 2, 2010, Pages 163-167

  Aokage, Keiju ^a   Yoshida, Junji ^a   Ishii, Genichiro ^a   Hishida, Tomoyuki ^a   Nishimura, Mitsuyo ^a   Nagai, Kanji ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Lymphadenectomy; Minimally invasive surgery; Non small cell lung cancer; Selective lymph node dissection; Subcarina; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; FEMALE; HISTOPATHOLOGY; HUMAN; LOBECTOMY; LUNG LOBE; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR LOCALIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS;

EID: 77957018816     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.02.009     Document Type: Article

References (47)

1. Churchill E.D., Sweet R.H., Soutter L., Scannell J.G. The surgical management of carcinoma of the lung: a study of the cases treated at the Massachusetts General Hospital from 1930 to 1950. J Thorac Surg 1950, 20:349-365.
2. Cahan W.G. Radical lobectomy. J Thorac Cardiovasc Surg 1960, 39:555-572.
3. Naruke T., Suemasu K., Ishikawa S. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. J Thorac Cardiovasc Surg 1976, 71:279-285.
4. Martini N., Flehinger B., Zaman M. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983, 198:386-397.
5. Naruke T., Goya T., Tsuchiya R. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastases. Ann Thorac Surg 1988, 46:603-609.
6. Sugi K., Nawata K., Fujita N., Ueda K., Tanaka T., Matsuoka T., et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2cm in diameter. World J Surg 1998, 22:290-294. [discussion 294-295].
7. Wu Y., Huang Z.F., Wang S.Y., Yang X.N., Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002, 36:1-6.
8. Izbicki J.R., Thetter O., Habekost M., Karg O., Passlick B., Kubuschok B., et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 1994, 81:229-235.
9. Wright G., Manser R.L., Byrnes G., Hart D., Campbell D.A. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax 2006, 61:597-603.
10. Naruke T., Goya T., Tsuchiya R. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988, 96:440-447.
11. Martini N., Flehinger B., Zaman M. Prospective study of 445 lung carcinoma with mediastinal lymph node metastases. J Thorac Cardiovasc Surg 1980, 80:390-399.
12. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622. [discussion 622-613].
13. Lewis R.J., Caccavale R.J., Sisler G.E., Mackenzie J.W. Video-assisted thoracic surgical resection of malignant lung tumors. J Thorac Cardiovasc Surg 1992, 104:1679-1685. [discussion 1685-1677].
14. Roviaro G., Rebuffat C., Varoli F., Vergani C., Mariani C., Maciocco M. Videoendoscopic pulmonary lobectomy for cancer. Surg Laparosc Endosc 1992, 2:244-247.
15. Park B.J., Flores R.M., Rusch V.W. Robotic assistance for video-assisted thoracic surgical lobectomy: technique and initial results. J Thorac Cardiovasc Surg 2006, 131:54-59.
16. Yoshida J., Nagai K., Yokose T., Nishimura M., Kakinuma R., Ohmatsu H., et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 2005, 129:991-996.
17. Read R.C., Yoder G., Schaeffer R.C. Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. Ann Thorac Surg 1990, 49:391-398. [discussion 399-400].
18. Pastorino U., Valente M., Bedini V., Infante M., Tavecchio L., Ravasi G. Limited resection for Stage I lung cancer. Eur J Surg Oncol 1991, 17:42-46.
19. Watanabe S., Asamura H., Suzuki K., Tsuchiya R. The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread. Interact Cardiovasc Thorac Surg 2005, 4:106-109.
20. Sugi K., Kaneda Y., Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg 2000, 24:27-30. [discussion 30-21].
21. Shigemura N., Akashi A., Nakagiri T., Ohta M., Matsuda H. Complete versus assisted thoracoscopic approach: a prospective randomized trial comparing a variety of video-assisted thoracoscopic lobectomy techniques. Surg Endosc 2004, 18:1492-1497.
22. Craig S.R., Leaver H.A., Yap P.L., Pugh G.C., Walker W.S. Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg 2001, 20:455-463.
23. Yoshida J. Management of the peripheral small ground-glass opacities. Thorac Surg Clin 2007, 17:191-201.
24. Nohl H.C. The spread of carcinoma of the bronchus 1962, Lloyd-Luke Ltd., London.
25. Riely G.J. The use of first-generation tyrosine kinase inhibitors in patients with NSCLC and somatic EGFR mutations. Lung Cancer 2008, 60(Suppl. 2):S19-S22.
26. Tibaldi C., Giovannetti E., Vasile E., Mey V., Laan A.C., Nannizzi S., et al. Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res 2008, 14:1797-1803.
27. Goldstein D.B., Tate S.K., Sisodiya S.M. Pharmacogenetics goes genomic. Nat Rev Genet 2003, 4:937-947.
28. Naruke T., Tsuchiya R., Kondo H., Nakayama H., Asamura H. Lymph node sampling in lung cancer: how should it be done?. Eur J Cardiothorac Surg 1999, 16(Suppl. 1):S17-S24.
29. Tanaka K., Kubota K., Kodama T., Nagai K., Nishiwaki Y. Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1-2 N0. Ann Thorac Surg 1999, 68:1039-1042.
30. Travis W., Coblby T., Corrin B., Shimosato Y., Brambilla E. Pathology and genetics of tumours of the lung, pleura, thymus and heart 1999, Springer Verlag, Berlin. 3rd ed.
31. Naruke T., Suemasu K., Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978, 76:832-839.
32. Kawasaki H., Nagai K., Yoshida J. The evaluation of subcarinal and inferior mediastinal lymph node dissection in upper lobe primary lung cancer. Jpn J Chest Surg 1997, 11:602-608. [in Japanese].
33. UICC TNM classification of malignant tumours 1997 and 2002, UICC, Geneva. 5th and 6th eds.
34. Okada M., Tsubota N., Yoshimura M., Miyamoto Y. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg 1998, 116:949-953.
35. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-360.
36. Kato H., Ichinose Y., Ohta M., Hata E., Tsubota N., Tada H., et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004, 350:1713-1721.
37. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005, 352:2589-2597.
38. Douillard J.Y., Rosell R., De Lena M., Carpagnano F., Ramlau R., Gonzales-Larriba J.L., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006, 7:719-727.
39. Strauss G.M., Herndon J.E., Maddaus M.A., Johnstone D.W., Johnson E.A., Harpole D.H., et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008, 26:5043-5051.
40. Ichinose Y., Kato H., Koike T., Tsuchiya R., Fujisawa T., Shimizu N., et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 2001, 122:803-808.
41. Okada M., Tsubota N., Yoshimura M., Miyamoto Y., Matsuoka H. Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival?. J Thorac Cardiovasc Surg 1999, 118:270-275.
42. Satoh Y., Okumura S., Nakagawa K., Horiike A., Ohyanagi F., Nishio M., et al. Postoperative ischemic change in bronchial stumps after primary lung cancer resection. Eur J Cardiothorac Surg 2006, 30:172-176.
43. Faber L.P., Piccione W. Lung cancer, principles and practice 2000, Lippincott Williams and Wilkins, Philadelphia. 2nd ed.
44. Allen M.S., Darling G.E., Pechet T.T., Mitchell J.D., Herndon J.E., Landreneau R.J., et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006, 81:1013-1019. [discussion 1019-1020].
45. Hasegawa I., Boiselle P.M., Kuwabara K., Sawafuji M., Sugiura H. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging. J Thorac Imaging 2008, 23:157-161.
46. Maziak D.E., Darling G.E., Inculet R.I., Gulenchyn K.Y., Driedger A.A., Ung Y.C., et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009, 151:221-228. W-248.
47. Hwangbo B., Kim S.K., Lee H.S., Lee H.S., Kim M.S., Lee J.M., et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2009, 135:1280-1287.